Civica plans to distribute its insulin glargine to pharmacies across the United States for $45 for a box of five pens. “Through the partnership we formed with Civica more than six years ago, BCBSA and ...

Mylan Pharmaceuticals recalled one batch of Insulin Glargine Injection, 100 units/mL (U-100), 3 mL prefilled pens, which are sold in cartons of five. Some pens might be missing their labels. In ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1. The insulin is from a state-branded form of the medicine, CalRx. Lawmakers ...

Californians with diabetes will soon have access to a low-cost insulin pen as part of a new state initiative announced today, October 16, by Gov. Gavin Newsom. Beginning Jan. 1, 2026, CalRx-branded ...

Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...

Gov. Gavin Newsom announced on Thursday that the first state-made insulin would be available at the start of 2026. California’s CalRx® Insulin Glargine in 3mL pen form will be $55 per five-pack.

(RTTNews) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml (U-100), 3mL ...